Analysis of functional urological surgery trends 2013-2024 in England using the HES database.
Abstract
[OBJECTIVE] To review recent trends in common functional urology surgery in England, using the Hospital Episode Statistics (HES) database.
[PATIENTS AND METHODS] Data between 2013 and 2024 were obtained from the HES database, a publicly available dataset recording details about procedures in NHS England. We recorded the procedures for treatment of female stress urinary incontinence (SUI), urgency urinary incontinence (UUI), post-prostatectomy incontinence (PPI), vesicovaginal fistula (VVF) and benign prostatic enlargement (BPE) surgery.
[RESULTS] Early in the study period, the most common procedures for SUI were insertion of transobturator and tension-free vaginal tape (8319 procedures/year). We observe an almost complete halt in tape insertion and an increase in removal from 2019 (8 procedures/year), due to concerns about complications and the 'mesh pause' in the UK. Injection of bulking agents became the mainstream treatment from 2019 (2490 procedures/year). For refractory UUI, intravesical Botulinum toxin A (BTX) remains the preferred treatment modality (9842 procedures/year). No significant increases in neuromodulation were observed (762/year), and numbers remain low for ileocystoplasty (100/year). Transurethral Resection of the Prostate (TURP) remains the commonest operation for BPE with 15,579 cases in 2023-2024. Laser resection modalities (Holmium laser Enucleation, or HoLEP, and Photoselective Vaporization of the Prostate, or PVP) saw increases with 5098 cases in 2023-2024. VVF repair numbers remain low, averaging 83 per year. There was a reduction in overall surgical numbers during the COVID-19 pandemic, with a partial recovery from 2022 onwards.
[CONCLUSION] Due to concerns around tape-related complications, bulking agents are now the mainstream treatment of SUI in women, and BTX in UUI. Whilst the use of laser is becoming increasingly popular, TURP remains the commonest procedure performed for BPE. There has only been a partial recovery in surgical numbers following the pandemic.
[PATIENTS AND METHODS] Data between 2013 and 2024 were obtained from the HES database, a publicly available dataset recording details about procedures in NHS England. We recorded the procedures for treatment of female stress urinary incontinence (SUI), urgency urinary incontinence (UUI), post-prostatectomy incontinence (PPI), vesicovaginal fistula (VVF) and benign prostatic enlargement (BPE) surgery.
[RESULTS] Early in the study period, the most common procedures for SUI were insertion of transobturator and tension-free vaginal tape (8319 procedures/year). We observe an almost complete halt in tape insertion and an increase in removal from 2019 (8 procedures/year), due to concerns about complications and the 'mesh pause' in the UK. Injection of bulking agents became the mainstream treatment from 2019 (2490 procedures/year). For refractory UUI, intravesical Botulinum toxin A (BTX) remains the preferred treatment modality (9842 procedures/year). No significant increases in neuromodulation were observed (762/year), and numbers remain low for ileocystoplasty (100/year). Transurethral Resection of the Prostate (TURP) remains the commonest operation for BPE with 15,579 cases in 2023-2024. Laser resection modalities (Holmium laser Enucleation, or HoLEP, and Photoselective Vaporization of the Prostate, or PVP) saw increases with 5098 cases in 2023-2024. VVF repair numbers remain low, averaging 83 per year. There was a reduction in overall surgical numbers during the COVID-19 pandemic, with a partial recovery from 2022 onwards.
[CONCLUSION] Due to concerns around tape-related complications, bulking agents are now the mainstream treatment of SUI in women, and BTX in UUI. Whilst the use of laser is becoming increasingly popular, TURP remains the commonest procedure performed for BPE. There has only been a partial recovery in surgical numbers following the pandemic.
추출된 의학 개체 (NER)
| 유형 | 영어 표현 | 한국어 / 풀이 | UMLS CUI | 출처 | 등장 |
|---|---|---|---|---|---|
| 시술 | botulinum toxin
|
보툴리눔독소 주사 | dict | 1 | |
| 합병증 | vesicovaginal fistula
|
scispacy | 1 | ||
| 합병증 | ileocystoplasty (
|
scispacy | 1 | ||
| 약물 | 8319
|
scispacy | 1 | ||
| 약물 | Holmium
|
C0019846
holmium
|
scispacy | 1 | |
| 약물 | SUI
→ stress urinary incontinence
|
C0042025
Urinary Stress Incontinence
|
scispacy | 1 | |
| 약물 | [OBJECTIVE]
|
scispacy | 1 | ||
| 약물 | urinary
|
scispacy | 1 | ||
| 약물 | PVP
|
scispacy | 1 | ||
| 약물 | COVID-19
|
scispacy | 1 | ||
| 질환 | stress urinary incontinence
|
C0042025
Urinary Stress Incontinence
|
scispacy | 1 | |
| 질환 | SUI
→ stress urinary incontinence
|
C0042025
Urinary Stress Incontinence
|
scispacy | 1 | |
| 질환 | urinary incontinence
|
C0042024
Urinary Incontinence
|
scispacy | 1 | |
| 질환 | UUI
→ urgency urinary incontinence
|
C0150045
Urge Incontinence
|
scispacy | 1 | |
| 질환 | incontinence
|
C0021167
Incontinence
|
scispacy | 1 | |
| 질환 | fistula
|
C0016169
pathologic fistula
|
scispacy | 1 | |
| 질환 | VVF
→ vesicovaginal fistula
|
C0042582
Vesicovaginal Fistula
|
scispacy | 1 | |
| 질환 | prostatic enlargement
|
C0426732
Large prostate
|
scispacy | 1 | |
| 질환 | BPE
→ benign prostatic enlargement
|
C1704272
Benign Prostatic Hyperplasia
|
scispacy | 1 | |
| 질환 | Prostate
|
C0033572
Prostate
|
scispacy | 1 | |
| 질환 | 15,579
|
scispacy | 1 | ||
| 질환 | tape-related complications
|
scispacy | 1 | ||
| 질환 | urological
|
scispacy | 1 | ||
| 질환 | NHS
|
scispacy | 1 | ||
| 질환 | benign prostatic
|
scispacy | 1 | ||
| 질환 | BTX
→ Botulinum toxin A
|
scispacy | 1 | ||
| 질환 | TURP
→ Transurethral Resection of the Prostate
|
scispacy | 1 | ||
| 기타 | HES
→ Hospital Episode Statistics
|
scispacy | 1 | ||
| 기타 | female
|
scispacy | 1 | ||
| 기타 | UUI
→ urgency urinary incontinence
|
scispacy | 1 | ||
| 기타 | VVF
→ vesicovaginal fistula
|
scispacy | 1 | ||
| 기타 | women
|
scispacy | 1 | ||
| 기타 | BTX
→ Botulinum toxin A
|
scispacy | 1 |
MeSH Terms
Humans; Female; Urologic Surgical Procedures; Databases, Factual; England; Male; Urinary Incontinence, Stress
📑 인용 관계
이 논문이 참조한 문헌 25
외부 PMID 25건 (DB 미수집)
- PMID 18313558 ↗
- PMID 19428076 ↗
- PMID 21795302 ↗
- PMID 22546389 ↗
- PMID 24007713 ↗
- PMID 24512557 ↗
- PMID 25273552 ↗
- PMID 25620532 ↗
- PMID 26209952 ↗
- PMID 29174616 ↗
- PMID 30718160 ↗
- PMID 32909173 ↗
- PMID 33551297 ↗
- PMID 33898508 ↗
- PMID 34688770 ↗
- PMID 34753471 ↗
- PMID 34994662 ↗
- PMID 36273485 ↗
- PMID 36414786 ↗
- PMID 37706750 ↗
- PMID 38651651 ↗
- PMID 38934789 ↗
- PMID 39820367 ↗
- PMID 40123518 ↗
- PMID 40247886 ↗
🔗 함께 등장하는 도메인
이 논문이 속한 카테고리와 같은 논문에서 자주 함께 다뤄지는 카테고리들
관련 논문
- Local therapeutic strategies for neurocutaneous dysesthesia: from capsaicin to cannabinoids.
- Comparative efficacy of intralesional therapies for keloid scars: a network meta-analysis.
- Adverse neurological events following botulinum toxin type A: A case series of post-injection seizures and paralysis.
- Decreased utilization of component separation techniques over time in complex abdominal wall reconstruction following introduction of preoperative botulinum toxin A.
- Current Perspectives on Pectoralis Minor Syndrome: A Narrative Review.